Home Cart Sign in  
Chemical Structure| 198821-22-6 Chemical Structure| 198821-22-6

Structure of Merimepodib
CAS No.: 198821-22-6

Chemical Structure| 198821-22-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Merimepodiba is a noncompetitive inhibitor of IMPDH (Inosine monophosphate dehydrogenase) with broad spectrum antiviral activities.

Synonyms: VX-497; MMPD; VI21497

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Merimepodib

CAS No. :198821-22-6
Formula : C23H24N4O6
M.W : 452.46
SMILES Code : COC1=C(C=CC(NC(NC2=CC=CC(CNC(O[C@H]3CCOC3)=O)=C2)=O)=C1)C4=CN=CO4
Synonyms :
VX-497; MMPD; VI21497
MDL No. :MFCD09837807
InChI Key :JBPUGFODGPKTDW-SFHVURJKSA-N
Pubchem ID :153241

Safety of Merimepodib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HEp-2 cells 1.1 µM Evaluate the inhibitory effect of VX-497 on RSV replication, IC50=1.1 µM, therapeutic index=9.0. PMC89783
L929 cells 1.0 µM Evaluate the inhibitory effect of VX-497 on EMCV replication, IC50=1.0 µM, therapeutic index=20.0. PMC89783
Vero cells 6.3 µM Evaluate the inhibitory effect of VX-497 on HSV-1 replication, IC50=6.3 µM, therapeutic index>4.9. PMC89783
Human foreskin fibroblast cells 0.8 µM Evaluate the inhibitory effect of VX-497 on HCMV replication, IC50=0.8 µM, therapeutic index=38.8. PMC89783
HepG2 2.2.15 cells 0.4 µM Evaluate the inhibitory effect of VX-497 on HBV replication, IC50=0.4 µM, therapeutic index=13.7. PMC89783
A549-ACE2 cells 10 µM 72 hours Evaluate the inhibitory activity of Merimepodib on SARS-CoV-2 replication, results showed IC50 of 21 µM PMC8722588
HEK-293T cells 10 µM 24 hours Evaluate the inhibitory activity of Merimepodib on SARS-CoV-2 nsp5, results showed IC50 close to 16 µM PMC8722588

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.21mL

0.44mL

0.22mL

11.05mL

2.21mL

1.11mL

22.10mL

4.42mL

2.21mL

References

 

Historical Records

Categories